Patents by Inventor Alexandra Briner Crawley

Alexandra Briner Crawley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200263186
    Abstract: The present invention is directed to modified CRISPR-cas guides that modulate the activity of Cas9 polypeptides to which the synthetic guides are complexed. In addition, methods of use of the modified CRISPR-guides are provided.
    Type: Application
    Filed: May 24, 2018
    Publication date: August 20, 2020
    Inventors: Rodolphe Barrangou, Alexandra Briner Crawley
  • Publication number: 20200157576
    Abstract: The present invention is directed to methods and compositions for typing of Lactobacillus buchneri bacterial strains, detecting the presence of a L. buchneri in a sample, identifying a strain of L. buchneri having resistance to an invasive foreign genetic element, modifying the resistance of bacteria and archeae to an invasive foreign genetic element, and introducing nicks into or cleaving double stranded DNA for genome editing.
    Type: Application
    Filed: January 28, 2020
    Publication date: May 21, 2020
    Inventors: Rodolphe Barrangou, Alexandra Briner Crawley
  • Publication number: 20190390223
    Abstract: The present invention is directed to methods and compositions comprising novel CRISPR polypeptides and polynucleotides for site-specific cleavage and nicking of nucleic acids, transcriptional control and genome editing.
    Type: Application
    Filed: September 6, 2019
    Publication date: December 26, 2019
    Inventors: Rodolphe Barrangou, Alexandra Briner Crawley
  • Publication number: 20190367949
    Abstract: Compositions and methods for binding to a target sequence of interest are provided. The compositions find use in cleaving or modifying a target sequence of interest, visualization of a target sequence of interest, and modifying the expression of a sequence of interest. Compositions comprise RNA-guided nuclease polypeptides, CRISPR RNAs, trans-activating CRISPR RNAs, guide RNAs, and nucleic acid molecules encoding the same. Vectors and host cells comprising the nucleic acid molecules are also provided. Further provided are CRISPR systems for binding a target sequence of interest, wherein the CRISPR system comprises an RNA-guided nuclease polypeptide and one or more guide RNAs.
    Type: Application
    Filed: June 5, 2019
    Publication date: December 5, 2019
    Applicant: LifeEDIT, Inc.
    Inventors: Alexandra Briner Crawley, Rodolphe Barrangou, Tyson D. Bowen, Michael Coyle, Tedd D. Elich